Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors'. Together they form a unique fingerprint.
Keyphrases
INIS
Pharmacology, Toxicology and Pharmaceutical Science